Loading stock analysis…
Evidence Synthesis
Last synthesized: 21 Oct 2026, 05:35
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence velocity
Rate-of-change signals for this ticker unlock with Pro — or view flagship demos TCS / RELIANCE.
Evidence Synthesis
EQUILATERA's quarterly performance is marked by a notable acceleration in its gross margin, which rose to 0.59% from -1.26%.
The company's revenue growth, however, remains negative, with a year-over-year decline of .4%. In contrast, its marginal operating leverage has decreased, moving from 0.23% to -1.26%. The daily volume has also decreased, falling from 1425 shares to 278 shares. The close price remained stable at 8.45 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 0.59 % | -1.26 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -1.26 % | 0.23 | ▼ |
| REVENUE_GROWTH_YOY | -37.4 % | -69.2 | ▲ |
| PRICE_CHANGE_PERCENT | 0 % | — | - |
| DAILY_VOLUME | 278 shares | 1,425 | ▼ |
| CLOSE_PRICE | 8.45 INR | 8.45 | - |
Cite this
Source: Samhati evidence synthesis for EQUILATERA (2026-10-21). Observation: EQUILATERA's quarterly performance is marked by a notable acceleration in its gross margin, which rose to 0.59% from -1.26%. Evidence quality: medium. Not investment advice — no buy, sell, or hold recommendation. Full narrative (Pro): https://samhati.ai/pricing Page: https://samhati.ai/stock/equilatera
Filing step-changes